By Iain Gilbert
Date: Wednesday 11 Oct 2023
(Sharecast News) - Digital solutions group Cambridge Cognition has secured a "significant contract" for a "sizeable" later-stage clinical trial, following a competitive tender.
By Josh White
Date: Tuesday 13 Jun 2023
(Sharecast News) - Brain health assessment specialist Cambridge Cognition has secured a £2m contract for a significant cancer therapy trial, it announced on Tuesday.
By Josh White
Date: Wednesday 12 Apr 2023
(Sharecast News) - Brain health technology specialist Cambridge Cognition has won two contracts worth more than £2.1m, it announced on Wednesday.
Currency | UK Pounds |
Share Price | 53.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 122.50 |
52 Week Low | 51.50 |
Volume | 14,000 |
Shares Issued | 34.96m |
Market Cap | £18.70m |
RiskGrade | 282 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
08:56 | 6,000 @ 53.07p |
08:48 | 8,000 @ 52.00p |
Chair | Steven John Powell |
CEO | Matthew Stork |
CFO | Stephen Symonds |
You are here: research